Sars-Cov-2 (Covid-19) Mrna-1273 (6M-5Y Bivalent Booster) Vaccine Dosage

Usual Pediatric Dose for COVID-19

For investigational use only

6 months to 5 years:

• Booster Dose: 0.2 mL IM once, at least 2 months after completing a primary vaccination series with this coronavirus disease 2019 (COVID-19) vaccine.

Comments:

• The US FDA issued an Emergency Use Authorization (EUA) to allow the emergency use of this unapproved product for active immunization to prevent COVID-19. This product is not approved by the US FDA for this use.
• There are no data available regarding interchangeability of COVID-19 vaccine products; the same vaccine product should be used for both doses.
• For additional information: https://www.fda.gov/emergency-preparedness-and-response/mcm-legal-regulatory-and-policy-framework/emergency-use-authorization

Use: Active immunization to prevent COVID-19 caused by SARS-CoV-2 (SARS-CoV-2) original and Omicron BA.4/BA.5

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS: Patients with known history of severe allergic reaction to the active component or any of the ingredients.

Safety and efficacy have not been established in patients younger than 6 months.

Dialysis

Data not available

Other Comments

Administration advice:

• Administer IM.
• Gently swirl the vial between doses; do not shake.

Storage requirements:

• Store frozen between -50C to -15C (-58F to 5F); store in original package to protect from light.
• Thaw each vial before use; once thawed, do not return vial to freezer.
• Thawed vials may be handled in room light conditions.
• Vials may be stored between 8C and 25C (46F to 77F) for a total of 24 hours.
• May store vials in refrigerator between 2C to 8C (36F to 46F) for up to 30 days prior to first use.
• In-use vial (needle-punctured): Store between 2C to 25C (36F to 77F); discard vial 8 hours after first puncture.
• Do not refreeze.

Reconstitution/preparation techniques:

• Do not dilute.

General:

• This information pertains only to the vaccine product supplied in a vial with a dark pink cap and label with a yellow border stating "Moderna COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)."
• Multiple dose vials contain two-0.2 mL doses of vaccine.
• Each dose must contain 0.2 mL of vaccine.
• If the vaccine remaining in the vial cannot provide a full 0.2 mL dose, discard the vial; do not pool excess vaccine from multiple vials.
• This vaccine may contain white or translucent particulates.

Patient advice:

• Read the Fact Sheet for Recipients and Caregivers.
• To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS): https://vaers.hhs.gov

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer